logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Musculoskeletal Diseases

    FiltersReset Filters
    14 results
    • carisoprodol

      (Carisoprodol)
      Chartwell RX, LLC
      Usage: Carisoprodol Tablets, USP are indicated for short-term relief of discomfort associated with acute, painful musculoskeletal conditions in adults. They should generally be used for up to two to three weeks, as longer use lacks adequate evidence of effectiveness.
    • carisoprodol

      (CARISOPRODOL)
      Vensun Pharmaceuticals, Inc.
      Usage: Carisoprodol is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. It is recommended for short-term use, typically up to two or three weeks, as prolonged effectiveness has not been established.
    • carisoprodol

      (carisoprodol)
      Aurobindo Pharma Limited
      Usage: Carisoprodol tablets are indicated for relieving discomfort from acute, painful musculoskeletal conditions in adults. Their use is limited to short durations (up to two or three weeks) due to lack of evidence supporting longer use and the typically short nature of these conditions.
    • chlorzoxazone

      (CHLORZOXAZONE)
      Camber Pharmaceuticals, Inc.
      Usage: Chlorzoxazone is indicated to relieve discomfort from acute, painful musculoskeletal conditions, used alongside rest and physical therapy. Its exact mechanism is unclear but may involve sedative effects, as it does not directly relax skeletal muscles.
    • chlorzoxazone

      (Chlorzoxazone)
      Par Pharmaceutical, Inc.
      Usage: Chlorzoxazone tablets are indicated as an adjunct to rest and physical therapy for relieving discomfort from acute painful musculoskeletal conditions. Its exact mode of action is unclear but may involve sedative properties; it does not directly relax skeletal muscles.
    • chlorzoxazone

      (CHLORZOXAZONE)
      Aurobindo Pharma Limited
      Usage: Chlorzoxazone is indicated as an adjunct treatment for relief of discomfort associated with acute, painful musculoskeletal conditions, alongside rest and physical therapy. Its precise mode of action is unclear but may involve sedative effects; it does not directly relax skeletal muscles.
    • chlorzoxazone

      (Chlorzoxazone)
      Actavis Pharma, Inc.
      Usage: Chlorzoxazone is indicated as an adjunct therapy to rest, physical therapy, and other treatments for relief of discomfort from acute, painful musculoskeletal conditions. Its exact mode of action is unclear but may involve sedative properties; it does not directly relax skeletal muscles.
    • cyclobenzaprine hydrochloride

      (Cyclobenzaprine Hydrochloride)
      Amneal Pharmaceuticals of New York LLC
      Usage: Cyclobenzaprine hydrochloride extended-release capsules are indicated as an adjunct to rest and physical therapy for relief of muscle spasms linked to acute, painful musculoskeletal conditions. Use is recommended for short durations (up to three weeks) as prolonged efficacy is unsupported. Not effective for spasticity in cerebral disease or children with cerebral palsy.
    • metaxal

      (Metaxalone)
      Trifluent Pharma LLC
      Usage: Metaxalone is indicated as an adjunct to rest and physical therapy for relieving discomfort associated with acute musculoskeletal conditions. Its exact mechanism is unclear but may involve sedative effects; it does not directly relax skeletal muscles.
    • metaxalone

      (Metaxalone)
      Amneal Pharmaceuticals of New York LLC
      Usage: Metaxalone tablets are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults and pediatric patients aged 13 and older, as an adjunct to rest, physical therapy, and other measures.